Literature DB >> 229805

Production of interferon by human tumor cell lines.

P Jameson, S E Grossberg.   

Abstract

Fourteen continuous human cell lines, including nine derived from tumors and five from non-neoplastic tissues, produced interferon in response to induction with bluetongue virus (BTV), Newcastle disease virus (NDV), and poly(I) . poly(C) complexed with DEAE-dextran. The seven best interferon-producing cell lines (one from a melanoma, five derived from carcinomas, and one SV40-virus-transformed kidney cell line) responded to at least one of the viral inducers with yields of interferon over 1000 units/ml. Because the HT-1376 bladder carcinoma cell line produced high yields of interferon in this survey, and is easily propagated, the optimal conditions for interferon production were investigated, using BTV as the inducer. Interferon yields in 59 inductions over a period of about two years consistently fell within a 6-fold range, and had a geometric mean titer of about 2700 reference units (RU)/ml, representing the production of about 3 RU/10(3) cells. This yield is comparable to mean titers of 1 to 10 RU/10(3) cells obtained by others with human leukocytes, foreskin cell strains, or the Namalva lymphoblastoid cell line. UV-inactivated BTV at a multiplicity corresponding to 10 PFU/cell was as effective an inducer in the HT-1376 cell line as the fully infectious virus at a multiplicity of 1 PFU/cell. The interferon produced by the HT-1376 epithelial cell line has characteristics similar to the interferon induced by poly(I) . poly(C) in human diploid fibroblasts. These studies clearly demonstrate that many different types of tumor-derived cells have the capacity to produce interferon, and that some equal or surpass the efficiency of diploid cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229805     DOI: 10.1007/bf01317553

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  40 in total

1.  Production of human lymphoblastoid interferon.

Authors:  H Strander; K E Mogensen; K Cantell
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

2.  Production of human lymphoblastoid interferon by Namalva cells.

Authors:  K C Zoon; C E Buckler; P J Bridgen; D Gurari-Rotman
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

3.  Production of antibody to tetanus toxoid by continuous human lymphoblastoid cell lines.

Authors:  V R Zurawski; E Haber; P H Black
Journal:  Science       Date:  1978-03-31       Impact factor: 47.728

4.  Towards the clinical use of interferon.

Authors:  K Cantell
Journal:  Endeavour       Date:  1978       Impact factor: 0.444

5.  Human interferon: mass production in a newly established cell line, MG-63.

Authors:  A Billiau; V G Edy; H Heremans; J Van Damme; J Desmyter; J A Georgiades; P De Somer
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

6.  Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.

Authors:  G Klein; L Dombos; B Gothoskar
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

7.  Mass production and some characteristics of human interferon from diploid cells.

Authors:  E A Havell; J Vilcek
Journal:  In Vitro Monogr       Date:  1974

8.  Inhibition by interferon preparations of a solid malignant tumour and pulmonary metastasis in mice.

Authors:  I Gresser; C Bourali-Maury
Journal:  Nat New Biol       Date:  1972-03-22

9.  The neuraminidase yield-reduction bioassay of human other interferons.

Authors:  J J Sedmak; S E Grossberg; P Jameson
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

10.  Human lymphoblastoid cells as a source of interferon.

Authors:  N B Finter; K H Fantes; M Johnston
Journal:  Dev Biol Stand       Date:  1977 Apr 13-15
View more
  9 in total

1.  NS3 of bluetongue virus interferes with the induction of type I interferon.

Authors:  Emilie Chauveau; Virginie Doceul; Estelle Lara; Emmanuel Breard; Corinne Sailleau; Pierre-Olivier Vidalain; Eliane F Meurs; Stéphanie Dabo; Isabelle Schwartz-Cornil; Stéphan Zientara; Damien Vitour
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

Review 2.  Roles of interferon produced in physiological conditions. A speculative review.

Authors:  V Bocci
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

3.  Production of high levels of human leukocyte interferon from a continuous human myeloblast cell culture.

Authors:  P C Familletti; R McCandliss; S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

4.  Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines.

Authors:  Sateesh Krishnamurthy; Toru Takimoto; Ruth Ann Scroggs; Allen Portner
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Sensing and control of bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases.

Authors:  Emilie Chauveau; Virginie Doceul; Estelle Lara; Micheline Adam; Emmanuel Breard; Corinne Sailleau; Cyril Viarouge; Alexandra Desprat; Gilles Meyer; Isabelle Schwartz-Cornil; Suzana Ruscanu; Bernard Charley; Stéphan Zientara; Damien Vitour
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

6.  Ultrastructural localization of interferon receptors on the surfaces of cultured cells and erythrocytes.

Authors:  V M Kushnaryov; J J Sedmak; J W Bendler; S E Grossberg
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

7.  Interferon induction in bovine and feline monolayer cultures by four bluetongue virus serotypes.

Authors:  R W Fulton; N J Pearson
Journal:  Can J Comp Med       Date:  1982-01

8.  The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.

Authors:  Janine Kimpel; Carles Urbiola; Iris Koske; Reinhard Tober; Zoltan Banki; Guido Wollmann; Dorothee von Laer
Journal:  Viruses       Date:  2018-03-02       Impact factor: 5.048

Review 9.  Induction and control of the type I interferon pathway by Bluetongue virus.

Authors:  Damien Vitour; Virginie Doceul; Suzana Ruscanu; Emilie Chauveau; Isabelle Schwartz-Cornil; Stéphan Zientara
Journal:  Virus Res       Date:  2013-11-07       Impact factor: 3.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.